Sign in
4

Changes in Ownership

INOVIO PHARMACEUTICALS, INC. Filed Acc 0001055726-20-000008

Chief Executive Officer gave up 65,068 shares (to pay taxes)

  • Chief Executive Officer acquired 183,800 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Kim Jong Joseph · Chief Executive Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2020-03-05 Exercise or conversion : show line 1 in the form +120,100 1,220,807 D
2020-03-05 Shares withheld for taxes : show line 2 in the form −37,371 $9.80 $366,236 1,183,436 D
2020-03-08 Exercise or conversion : show line 3 in the form +63,700 1,247,136 D
2020-03-08 Shares withheld for taxes : show line 4 in the form −27,697 $14.09 $390,251 1,219,439 D

Table II: Derivative

2 lines
Date Transaction Shares Underlying Owned after D/I
2020-03-05 Exercise or conversion : show line 5 in the form Restricted Stock Unit −120,100 120,100 120,100 D
2020-03-08 Exercise or conversion : show line 6 in the form Restricted Stock Unit −63,700 63,700 127,400 D
Loading xslF345X03/wf-form4_158378508254040.xml…